IQSM:NYE-Iq Candriam ESG U.S. Mid Cap Equity ETF (USD)

ETF | Others |

Last Closing

USD 32.874

Change

+0.00 (+0.01)%

Market Cap

N/A

Volume

100.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.15 (-0.67%)

USD 65.72B
SOJE Southern Company (The) Series ..

-0.15 (-0.67%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.10 (+0.17%)

USD 35.71B
JEPI JPMorgan Equity Premium Income..

+0.10 (+0.17%)

USD 35.71B
DFAC Dimensional U.S. Core Equity 2..

+0.10 (+0.29%)

USD 31.07B
DFAC Dimensional U.S. Core Equity 2..

+0.10 (+0.29%)

USD 31.07B
DTB DTE Energy Company 2020 Series

-0.32 (-1.48%)

USD 26.58B
DTB DTE Energy Company 2020 Series

-0.32 (-1.48%)

USD 26.58B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 25.99B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 25.99B

ETFs Containing IQSM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.17% 55% F 53% F
Dividend Return 0.88% 15% F 15% F
Total Return 10.05% 53% F 47% F
Trailing 12 Months  
Capital Gain 24.81% 69% C- 65% D
Dividend Return 1.00% 11% F 11% F
Total Return 25.81% 67% D+ 60% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.85% N/A N/A 55% F
Dividend Return 5.19% N/A N/A 48% F
Total Return 0.34% N/A N/A 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 7.26% N/A N/A 84% B
Risk Adjusted Return 71.51% N/A N/A 84% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike